Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 28, 2020	Mar. 29, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 28, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ (92,217)	$ 69,695	$ 195,631	$ 127,945	$ (22,522)	$ 323,576
Adjustments to reconcile Net (loss) income to Net cash provided by operating activities:
Depreciation and amortization					95,454	125,386
Amortization of deferred loan origination costs					33,796	38,036
Amortization of financing origination fees					6,661	4,522
Provision for long-term employee benefits					15,704	6,936
Employee benefit plan contributions and payments					(3,678)	(3,637)
Stock compensation expense					4,568	17,285
Net change in wholesale finance receivables related to sales					166,049	(167,594)
Provision for credit losses	91,179		26,383		170,598	60,874
Deferred income taxes					(19,461)	5,368
Other, net					(9,294)	(10,477)
Changes in current assets and liabilities:
Accounts receivable, net					(15,747)	(17,592)
Finance receivables – accrued interest and other					(2,985)	(4,963)
Inventories, net					163,700	88,146
Accounts payable and accrued liabilities					10,664	34,370
Derivative financial instruments					1,538	4,352
Other					15,158	(8,356)
Total adjustments					632,725	172,656
Net cash provided by operating activities					610,203	496,232
Cash flows from investing activities:
Capital expenditures					(67,026)	(83,229)
Origination of finance receivables					(1,869,569)	(2,064,899)
Collections on finance receivables					1,785,698	1,768,829
Sales and redemptions of marketable securities					0	10,007
Acquisition of business					0	(7,000)
Other investing activities					(381)	11,717
Net cash used by investing activities					(151,278)	(364,575)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					1,396,602	546,655
Repayments of medium-term notes					(1,400,000)	(750,000)
Proceeds from securitization debt					2,064,450	1,021,353
Repayments of securitization debt					(369,613)	(113,806)
Borrowings of asset-backed commercial paper					225,187	23,373
Repayments of asset-backed commercial paper					(143,306)	(155,286)
Net increase in unsecured commercial paper					831,354	(728,606)
Net increase in credit facilities					150,000	0
Deposits					17,995	0
Dividends paid					(61,917)	(120,841)
Repurchase of common stock					(7,156)	(104,621)
Issuance of common stock under share-based plans					41	833
Net cash provided (used) by financing activities					2,703,637	(380,946)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(382)	3,439
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		905,366		1,259,748	905,366	1,259,748
Net increase (decrease) in cash, cash equivalents and restricted cash					3,162,180	(245,850)
Cash, cash equivalents and restricted cash, end of period	4,067,546		1,013,898		4,067,546	1,013,898
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt					0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt					2,064,450
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net (loss) income	(96,964)		184,200		55,462	313,614
Adjustments to reconcile Net (loss) income to Net cash provided by operating activities:
Depreciation and amortization					91,298	121,026
Amortization of deferred loan origination costs					0	0
Amortization of financing origination fees					339	335
Provision for long-term employee benefits					15,704	6,936
Employee benefit plan contributions and payments					(3,678)	(3,637)
Stock compensation expense					4,019	15,672
Net change in wholesale finance receivables related to sales					0	0
Provision for credit losses	0		0		0	0
Deferred income taxes					5,602	5,928
Other, net					(12,635)	(8,545)
Changes in current assets and liabilities:
Accounts receivable, net					(198,855)	(244,752)
Finance receivables – accrued interest and other					0	0
Inventories, net					163,700	88,146
Accounts payable and accrued liabilities					(1,001)	21,336
Derivative financial instruments					1,622	4,291
Other					(9,999)	(15,573)
Total adjustments					56,116	(8,837)
Net cash provided by operating activities					111,578	304,777
Cash flows from investing activities:
Capital expenditures					(65,677)	(81,698)
Origination of finance receivables					0	0
Collections on finance receivables					0	0
Sales and redemptions of marketable securities						10,007
Acquisition of business						(7,000)
Other investing activities					(381)	11,717
Net cash used by investing activities					(66,058)	(66,974)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					0	0
Repayments of medium-term notes					0	0
Proceeds from securitization debt						0
Repayments of securitization debt					0	0
Borrowings of asset-backed commercial paper					0	0
Repayments of asset-backed commercial paper					0	0
Net increase in unsecured commercial paper					0	0
Net increase in credit facilities					0
Deposits					0
Dividends paid					(61,917)	(120,841)
Repurchase of common stock					(7,156)	(104,621)
Issuance of common stock under share-based plans					41	833
Net cash provided (used) by financing activities					(69,032)	(224,629)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(712)	2,724
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		470,649		544,548	470,649	544,548
Net increase (decrease) in cash, cash equivalents and restricted cash					(24,224)	15,898
Cash, cash equivalents and restricted cash, end of period	446,425		560,446		446,425	560,446
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net (loss) income	4,672		56,453		21,627	99,906
Adjustments to reconcile Net (loss) income to Net cash provided by operating activities:
Depreciation and amortization					4,156	4,360
Amortization of deferred loan origination costs					33,796	38,036
Amortization of financing origination fees					6,322	4,187
Provision for long-term employee benefits					0	0
Employee benefit plan contributions and payments					0	0
Stock compensation expense					549	1,613
Net change in wholesale finance receivables related to sales					0	0
Provision for credit losses	91,179		26,383		170,598	60,874
Deferred income taxes					(24,592)	(236)
Other, net					3,730	(1,876)
Changes in current assets and liabilities:
Accounts receivable, net					0	0
Finance receivables – accrued interest and other					(2,985)	(4,963)
Inventories, net					0	0
Accounts payable and accrued liabilities					214,864	221,959
Derivative financial instruments					(84)	61
Other					3,150	13,091
Total adjustments					409,504	337,106
Net cash provided by operating activities					431,131	437,012
Cash flows from investing activities:
Capital expenditures					(1,349)	(1,531)
Origination of finance receivables					(3,033,567)	(3,936,208)
Collections on finance receivables					3,117,190	3,484,581
Sales and redemptions of marketable securities						0
Acquisition of business						0
Other investing activities					0	0
Net cash used by investing activities					82,274	(453,158)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					1,396,602	546,655
Repayments of medium-term notes					(1,400,000)	(750,000)
Proceeds from securitization debt						1,021,353
Repayments of securitization debt					(369,613)	(113,806)
Borrowings of asset-backed commercial paper					225,187	23,373
Repayments of asset-backed commercial paper					(143,306)	(155,286)
Net increase in unsecured commercial paper					831,354	(728,606)
Net increase in credit facilities					150,000
Deposits					17,995
Dividends paid					(100,000)	(90,000)
Repurchase of common stock					0	0
Issuance of common stock under share-based plans					0	0
Net cash provided (used) by financing activities					2,672,669	(246,317)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					330	715
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		434,717		715,200	434,717	715,200
Net increase (decrease) in cash, cash equivalents and restricted cash					3,186,404	(261,748)
Cash, cash equivalents and restricted cash, end of period	3,621,121		453,452		3,621,121	453,452
Consolidating Adjustments
Cash flows from operating activities:
Net (loss) income	75		(45,022)		(99,611)	(89,944)
Adjustments to reconcile Net (loss) income to Net cash provided by operating activities:
Depreciation and amortization					0	0
Amortization of deferred loan origination costs					0	0
Amortization of financing origination fees					0	0
Provision for long-term employee benefits					0	0
Employee benefit plan contributions and payments					0	0
Stock compensation expense					0	0
Net change in wholesale finance receivables related to sales					166,049	(167,594)
Provision for credit losses	0		0		0	0
Deferred income taxes					(471)	(324)
Other, net					(389)	(56)
Changes in current assets and liabilities:
Accounts receivable, net					183,108	227,160
Finance receivables – accrued interest and other					0	0
Inventories, net					0	0
Accounts payable and accrued liabilities					(203,199)	(208,925)
Derivative financial instruments					0	0
Other					22,007	(5,874)
Total adjustments					167,105	(155,613)
Net cash provided by operating activities					67,494	(245,557)
Cash flows from investing activities:
Capital expenditures					0	0
Origination of finance receivables					1,163,998	1,871,309
Collections on finance receivables					(1,331,492)	(1,715,752)
Sales and redemptions of marketable securities						0
Acquisition of business						0
Other investing activities					0	0
Net cash used by investing activities					(167,494)	155,557
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					0	0
Repayments of medium-term notes					0	0
Proceeds from securitization debt					0	0
Repayments of securitization debt					0	0
Borrowings of asset-backed commercial paper					0	0
Repayments of asset-backed commercial paper					0	0
Net increase in unsecured commercial paper					0	0
Net increase in credit facilities					0
Deposits					0
Dividends paid					100,000	90,000
Repurchase of common stock					0	0
Issuance of common stock under share-based plans					0	0
Net cash provided (used) by financing activities					100,000	90,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash					0	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		$ 0		$ 0	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash					0	0
Cash, cash equivalents and restricted cash, end of period	$ 0		$ 0		$ 0	$ 0